Regulacje i polityka gospodarcza · 30/11/1995

Notice of Prospective Patent License

NASA hereby gives notice that Crystal Systems, Inc., of Decatur, Alabama, has applied for an exclusive license to practice the inventions described and claimed in (1) U.S. Patent No. 4,833,233 entitled Human Serum Albumin Crystals and Method of Preparation, (2) U.S. Patent Application Serial No. 08/351,861 entitled Crystals of Serum Albumin for Use in Genetic Engineering and Rational Drug Design, (3) U.S. Patent Application Serial No. 08/448,196 entitled Biologically Active Protein Fragments Containing Specific Binding Regions of Serum Albumin or Related Proteins, and (4) U.S. Patent Application Serial No. 08/422,963 entitled Device and Method for Screening Crystallization Conditions in Solution Crystal Growth, all of which are assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. Written objections to the prospective grant of a license to Crystal Systems, Inc. should be sent to Jerry L. Seemann at NASA/Marshall Space Flight Center, CC01/ Office of Chief Counsel, Huntsville, Alabama 35812.